⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1031265 | 0.79 | — | — | |
| SCHEMBL295682 | 0.75 | — | — | |
| SCHEMBL127281 | 0.75 | — | — | |
| SCHEMBL27588698 | 0.72 | ALOX15 (0.41) | — | |
| SCHEMBL61229 | 0.70 | — | — | |
| SCHEMBL15121292 | 0.70 | MAPK1 (0.33) | — | |
| SCHEMBL27588472 | 0.69 | USP7 (0.42) | — | |
| SCHEMBL6025555 | 0.69 | — | — | |
| SCHEMBL27259853 | 0.69 | — | — | |
| SCHEMBL183542 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1728 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49934-E1 | Inhibitors of cellular metabolic processes | SERVIER PHARMACEUTICALS LLC (US) | 2024-04-23 | — | — | US | claimed |
| WO-2023210818-A1 | COMPOSITION INCLUDING FLUORORUBBER | ダイキン工業株式会社 | 2023-11-02 | — | — | WO | claimed |
| CN-113061337-B | Resin composition | 财团法人工业技术研究院 | 2023-05-16 | — | — | CN | claimed |
| CN-109890822-B | Inhibitors of cellular metabolic processes | 安吉奥斯医药品有限公司 | 2022-08-30 | — | — | CN | claimed |
| US-11325914-B1 | Inhibitors of cellular metabolic processes | SERVIER PHARMACEUTICALS LLC (US) | 2022-05-10 | — | — | US | claimed |
| WO-2021158792-A1 | METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY DISEASES OR DISORDERS | AGIOS PHARMACEUTICALS, INC. (US) | 2021-08-12 | — | — | WO | claimed |
| CN-113061337-A | Resin composition | 财团法人工业技术研究院 | 2021-07-02 | — | — | CN | claimed |
| EP-2915186-B1 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | VERSUM MAT US LLC (US) | 2020-10-28 | — | — | EP | claimed |
| US-10800782-B2 | Inhibitors of cellular metabolic processes | Agios Pharmaceutical, Inc. (US) | 2020-10-13 | — | — | US | claimed |
| US-20190233424-A1 | INHIBITORS OF CELLULAR METABOLIC PROCESSES | SERVIER PHARMACEUTICALS LLC | 2019-08-01 | — | — | US | claimed |
| CN-1500715-A | Lamination and picture composition method utilizing chemical self-assembly process | ���ǵ�����ʽ���� | 2004-06-02 | — | — | CN | claimed |
| EP-1383497-A2 | CARBONIC ANHYDRASE ACTIVATORS FOR ENHANCING LEARNING AND MEMORY | Blanchette Rockefeller Neurosciences Institute (US) | 2004-01-28 | — | — | EP | claimed |
| CN-1468907-A | Photosensitive polyimide resin precursor composition, optical polyimide, light wave guide tube and process for producing the same light wave guide tube | �ն��繤��ʽ���� | 2004-01-21 | — | — | CN | claimed |
| CN-1444477-A | Thrombopoietin mimetics | SMITHKLINE BEECHAM CORP (US) | 2003-09-24 | — | — | CN | claimed |
| US-20030149072-A1 | Substituted arylcycloalkanes, compositions containing them and use thereof | AVENTIS PHARMA S.A. (FR) | 2003-08-07 | — | — | US | claimed |
| WO-2003048096-A1 | SUBSTITUTED ARYL-CYCLOALKANES, AND USE THEREOF AS ANTICANCER AGENTS | AVENTIS PHARMA S.A. (FR) | 2003-06-12 | — | — | WO | claimed |
| WO-2002087423-A2 | CARBONIC ANHYDRASE ACTIVATORS FOR ENHANCING LEARNING AND MEMORY | BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE (US) | 2002-11-07 | — | — | WO | claimed |
| CN-1043717-A | Cephalosporin compound | TANABE SEIYAKU CO (JP) | 1990-07-11 | — | — | CN | claimed |
| EP-0376724-A2 | Cephalosporin compounds | TANABE SEIYAKU CO., LTD. (JP) | 1990-07-04 | — | — | EP | claimed |
| US-4009156-A | Hydroxynaphthalene trisazo dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | claimed |